UK To Add India’s Covaxin To Approved List From November 22

1
(1)

The UK government has informed that India’s Covaxin will be added to its list of approved COVID-19 vaccines for international travellers from November 22, meaning that those inoculated with the Bharat Biotech-manufactured jab will not have to self-isolate after arrival in England.

According to the reports, Alex Ellis, British High Commissioner to India, tweeted- “More good news for Indian travellers to the UK. From 22 November travellers fully vaccinated with a COVID19 vaccine recognised by WHO for Emergency Use Listing, including Covaxin, will not have to self-isolate; so, joining those fully vaccinated with Covishield.”

Covishield, the India-manufactured Oxford-AstraZeneca COVID-19 vaccine, was added to the UK’s approved list last month and the changes will come into effect at 4 am on November 22. Besides Covaxin, China’s Sinovac and Sinopharm, both on the WHO Emergency Use Listing, will be recognised by the UK government as approved vaccines for inbound travel, benefitting fully vaccinated people from the United Arab Emirates and Malaysia. These fully vaccinated passengers will not be required to take a pre-departure test, day-8 test or self-isolate upon arrival.

The UK government has also simplified the travel rules for all under-18s coming to England. They will now be treated as fully vaccinated at the border and will be exempt from self-isolation requirements on arrival, day-8 testing and pre-departure testing. They will only be required to take one post-arrival test and a confirmatory free PCR test if they test positive.

Pic Courtesy – Google

Do you find this post useful?

Click on a star to rate it!

Average rating 1 / 5. Vote count: 1

No votes so far! Be the first to rate this post.

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Subscribe to our Newsletter

Leave a Comment